Tag: ReCor Medical. RADIANCE-HTN TRIO

ReCor Medical Announces Consistent Reduction of Blood Pressure in Pooled Analysis of Three Clinical Trials at AHA 2022

Compiled Data from RADIANCE Global Program Show Consistent Treatment Effect and Safety Across Broad Patient Population PALO ALTO, Calif.–(BUSINESS WIRE)–ReCor Medical, Inc. (“ReCor”) and its parent company, Otsuka Medical Devices Co., Ltd. today announced consistent and significant blood pressure (“BP”) lowering results across a range of patients with uncontrolled hypertension, including across […]